Antibody | Target Species | P/M | Source (Company) | Standards | Results (+/−)1-a |
---|---|---|---|---|---|
1A1 | Rat | P | XenoTech | 3MC | − |
1A1/2 | Rat | P | XenoTech | 3MC | − |
1A1/2 | Rabbit | P | Oxford Biomedical | 3MC | + |
2A6 | Human | M | Gentest | 2A6 | + |
2B1/2 | Rat | M | Oxford Biomedical | PB and 2B6 | − |
2B1/2 | Rat | P | Oxford Biomedical | PB and 2B6 | + |
2B1/2 | Rat | P | XenoTech | PB and 2B6 | + |
2D6 | Human | M | Gentest | 2D6 | + |
2E1 | Rat | P | XenoTech | Acetone | + |
2E1 | Rat | P | Gentest1-b | Acetone | + |
3A1/2 | Rat | P | XenoTech | DEX | + |
4A1/3 | Rat | P | Gentest | Clofibrate | + |
P/M, polyclonal or monoclonal antibody; 3MC, 3-methylcholanthrene; DEX, dexamethasone; recombinant human 2B6; recombinant human 2D6.
↵1-a (+/−), positive (+) or negative (−) antibody binding (Western blot) using swine liver microsomes. All western blot analyses used a concurrent positive control appropriate for the test primary antibody.
↵1-b Cross-reacts with rat 2C11 and 2C13. No evidence of cross-reactivity with swine 2C11 or 2C13 was observed.